Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $3.04 Analyst target: $17.53 Upside: 476.64%
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health safety and infectious disease markets in the United States. The company is headquartered in New York, New York.
See the full interactive analysis & chart →Informational only — not investment advice.